The Possible Role of p53 and bcl-2 Expression in Cervical Carcinomas and Their Premalignant Lesions
- 1 April 2000
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 77 (1), 129-136
- https://doi.org/10.1006/gyno.1999.5715
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomasHuman Pathology, 1995
- The role of p53 inactivation in human cervical cell carcinoma developmentBritish Journal of Cancer, 1995
- Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomasCancer Genetics and Cytogenetics, 1995
- p53 and behaviour of colorectal cancerThe Lancet, 1994
- bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancerBritish Journal of Cancer, 1994
- p53 function and dysfunctionCell, 1992
- Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumoursThe Lancet, 1992
- Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6Nature, 1991
- The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53Cell, 1990
- Increased expression of p53 protein in human leukemia cells.Proceedings of the National Academy of Sciences of the United States of America, 1986